Bradley E. Lerman
Net Worth
Last updated:
What is Bradley E. Lerman net worth?
The estimated net worth of Mr. Bradley E. Lerman is at least $39,412,264 as of 30 Sep 2021. He owns shares worth $4,387,207 as insider, has earned $15,215,057 from insider trading and has received compensation worth at least $19,810,000 in Medtronic plc.
What is the salary of Bradley E. Lerman?
Mr. Bradley E. Lerman salary is $2,830,000 per year as Senior Vice President, Gen. Counsel & Corporation Sec. in Medtronic plc.
How old is Bradley E. Lerman?
Mr. Bradley E. Lerman is 69 years old, born in 1956.
What stocks does Bradley E. Lerman currently own?
As insider, Mr. Bradley E. Lerman owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Medtronic plc (MDT) | Senior Vice President, Gen. Counsel & Corporation Sec. | 48,763 | $89.97 | $4,387,207 |
What does Medtronic plc do?
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Bradley E. Lerman insider trading
Medtronic plc
Mr. Bradley E. Lerman has made 9 insider trades between 2018-2021, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 50,775 units of MDT stock on 31 Aug 2021. As of 30 Sep 2021 he still owns at least 48,763 units of MDT stock.